Related Experiment Video
Updated: Mar 9, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Immune reconstitution inflammatory syndrome associated with pulmonary pathogens
Radha Gopal1, Rekha R Rapaka2, Jay K Kolls3
1Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
Immune reconstitution inflammatory syndrome (IRIS) involves an overactive immune response in HIV patients. Research using animal models aims to uncover mechanisms of pulmonary IRIS for better treatments.
Area of Science:
- Immunology
- Infectious Diseases
- HIV/AIDS Research
Background:
- Immune reconstitution inflammatory syndrome (IRIS) is an exaggerated immune response during antiretroviral therapy in HIV-infected individuals.
- Pulmonary IRIS, linked to opportunistic infections like tuberculosis, significantly increases morbidity and mortality.
- While various immune factors are implicated, the precise mechanisms driving pulmonary IRIS remain unclear.
Purpose of the Study:
- To elucidate the poorly understood mechanisms underlying the development of pulmonary IRIS.
- To identify specific molecular targets involved in pulmonary IRIS pathogenesis.
- To pave the way for potential biomarkers and therapeutic strategies for pulmonary IRIS.
Main Methods:
- Proposing the use of gene-deficient murine models.
- Suggesting the application of nonhuman primate models.
- Focusing on identifying specific molecular targets through these models.
Main Results:
- This study proposes a research direction rather than presenting experimental results.
- The proposed research aims to identify key molecular players in pulmonary IRIS.
- The expected outcome is a clearer understanding of IRIS mechanisms.
Conclusions:
- Understanding pulmonary IRIS mechanisms is crucial for managing HIV-associated opportunistic infections.
- Gene-deficient and nonhuman primate models are proposed as valuable tools for IRIS research.
- Identifying molecular targets will facilitate the development of novel biomarkers and therapies for pulmonary IRIS.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
Related Concept Videos
Myocarditis I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions